Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Crossover Study to Evaluate Bolus Versus Continuous Infusion of Lumason® in Patients With Suboptimal Unenhanced Echocardiography

NCT06400004 is registered in ClinicalTrials.gov with Bracco Diagnostics, Inc as lead sponsor.

NCT NCT06400004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06400004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Crossover Study to Evaluate Bolus Versus Continuous Infusion of Lumason® in Patients With Suboptimal Unenhanced Echocardiography
Lead sponsor
Bracco Diagnostics, Inc
Phase
Phase 3
Overall status
Recruiting
Start date
July 10, 2024
Completion date
December 31, 2026
Enrollment
106 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

heart diseases